Annual Accounts Payable
$618.00 K
-$1.04 M-62.77%
31 December 2023
Summary:
Achieve Life Sciences annual accounts payable is currently $618.00 thousand, with the most recent change of -$1.04 million (-62.77%) on 31 December 2023. During the last 3 years, it has risen by +$286.00 thousand (+86.14%). ACHV annual accounts payable is now -89.10% below its all-time high of $5.67 million, reached on 31 December 2005.ACHV Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.01 M
+$461.00 K+83.82%
30 September 2024
Summary:
Achieve Life Sciences quarterly accounts payable is currently $1.01 million, with the most recent change of +$461.00 thousand (+83.82%) on 30 September 2024. Over the past year, it has increased by +$373.00 thousand (+58.46%). ACHV quarterly accounts payable is now -82.16% below its all-time high of $5.67 million, reached on 31 December 2005.ACHV Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHV Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.8% | +58.5% |
| 3 y3 years | +86.1% | +24.1% |
| 5 y5 years | +329.2% | +76.1% |
ACHV Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -62.8% | +86.1% | -39.1% | +180.1% |
| 5 y | 5 years | -62.8% | +329.2% | -39.1% | +449.5% |
| alltime | all time | -89.1% | +758.3% | -82.2% | +2492.3% |
Achieve Life Sciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.01 M(+83.8%) |
| June 2024 | - | $550.00 K(+47.5%) |
| Mar 2024 | - | $373.00 K(-39.6%) |
| Dec 2023 | $618.00 K(-62.8%) | $618.00 K(-3.1%) |
| Sept 2023 | - | $638.00 K(+76.7%) |
| June 2023 | - | $361.00 K(-66.0%) |
| Mar 2023 | - | $1.06 M(-36.0%) |
| Dec 2022 | $1.66 M(+97.4%) | $1.66 M(+302.9%) |
| Sept 2022 | - | $412.00 K(-37.2%) |
| June 2022 | - | $656.00 K(+56.9%) |
| Mar 2022 | - | $418.00 K(-50.3%) |
| Dec 2021 | $841.00 K(+153.3%) | $841.00 K(+3.2%) |
| Sept 2021 | - | $815.00 K(+41.7%) |
| June 2021 | - | $575.00 K(-1.7%) |
| Mar 2021 | - | $585.00 K(+76.2%) |
| Dec 2020 | $332.00 K(-61.4%) | $332.00 K(+1.8%) |
| Sept 2020 | - | $326.00 K(-37.7%) |
| June 2020 | - | $523.00 K(+184.2%) |
| Mar 2020 | - | $184.00 K(-78.6%) |
| Dec 2019 | $859.00 K(+496.5%) | $859.00 K(+49.7%) |
| Sept 2019 | - | $574.00 K(-18.8%) |
| June 2019 | - | $707.00 K(+1.9%) |
| Mar 2019 | - | $694.00 K(+381.9%) |
| Dec 2018 | $144.00 K(-32.4%) | $144.00 K(-68.6%) |
| Sept 2018 | - | $458.00 K(+82.5%) |
| June 2018 | - | $251.00 K(-40.2%) |
| Mar 2018 | - | $420.00 K(+97.2%) |
| Dec 2017 | $213.00 K(+124.2%) | $213.00 K(-57.0%) |
| Sept 2017 | - | $495.00 K(+112.4%) |
| June 2017 | - | $233.00 K(-35.1%) |
| Mar 2017 | - | $359.00 K(+277.9%) |
| Dec 2016 | $95.00 K(-92.9%) | $95.00 K(-90.9%) |
| Sept 2016 | - | $1.04 M(+86.6%) |
| June 2016 | - | $559.00 K(-5.6%) |
| Mar 2016 | - | $592.00 K(-55.9%) |
| Dec 2015 | $1.34 M(+1765.3%) | $1.34 M(-24.5%) |
| Sept 2015 | - | $1.78 M(+489.1%) |
| June 2015 | - | $302.00 K(-69.4%) |
| Mar 2015 | - | $988.00 K(+1272.2%) |
| Dec 2014 | $72.00 K(-48.2%) | $72.00 K(-95.4%) |
| Sept 2014 | - | $1.56 M(+16.5%) |
| June 2014 | - | $1.34 M(+45.3%) |
| Mar 2014 | - | $923.00 K(+564.0%) |
| Dec 2013 | $139.00 K(-89.5%) | $139.00 K(+256.4%) |
| Sept 2013 | - | $39.00 K(-70.0%) |
| June 2013 | - | $130.00 K(-90.2%) |
| Dec 2012 | $1.33 M | $1.33 M(-50.8%) |
| Sept 2008 | - | $2.70 M(+1682.2%) |
| June 2008 | - | $151.50 K(-89.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $1.43 M(-2.3%) |
| Dec 2007 | $1.46 M(-38.4%) | $1.46 M(-50.0%) |
| Sept 2007 | - | $2.92 M(+52.9%) |
| June 2007 | - | $1.91 M(+3.5%) |
| Mar 2007 | - | $1.85 M(-22.1%) |
| Dec 2006 | $2.37 M(-58.2%) | $2.37 M(+88.3%) |
| Sept 2006 | - | $1.26 M(-20.1%) |
| June 2006 | - | $1.58 M(+329.1%) |
| Mar 2006 | - | $367.60 K(-93.5%) |
| Dec 2005 | $5.67 M(+78.4%) | $5.67 M(+3.2%) |
| Sept 2005 | - | $5.49 M(+143.1%) |
| June 2005 | - | $2.26 M(+1.0%) |
| Mar 2005 | - | $2.24 M(-29.6%) |
| Dec 2004 | $3.18 M(+68.4%) | $3.18 M(+41.0%) |
| Sept 2004 | - | $2.25 M(-5.0%) |
| June 2004 | - | $2.37 M(+34.5%) |
| Mar 2004 | - | $1.76 M(-6.6%) |
| Dec 2003 | $1.89 M(+4.8%) | $1.89 M(-22.6%) |
| Sept 2003 | - | $2.44 M(+9.2%) |
| June 2003 | - | $2.23 M(+26.4%) |
| Mar 2003 | - | $1.76 M(-2.0%) |
| Dec 2002 | $1.80 M(+50.2%) | $1.80 M(-24.5%) |
| Sept 2002 | - | $2.38 M(+14.4%) |
| June 2002 | - | $2.08 M(+57.0%) |
| Mar 2002 | - | $1.33 M(+10.7%) |
| Dec 2001 | $1.20 M(+49.8%) | $1.20 M(+29.5%) |
| Mar 2001 | - | $925.30 K(+15.6%) |
| Dec 2000 | $800.30 K(-73.7%) | $800.30 K(-71.1%) |
| Sept 2000 | - | $2.77 M(+3.9%) |
| June 2000 | - | $2.66 M(+1.5%) |
| Mar 2000 | - | $2.62 M(-13.8%) |
| Dec 1999 | $3.04 M(+1.4%) | $3.04 M(-24.0%) |
| Sept 1999 | - | $4.00 M(+14.3%) |
| June 1999 | - | $3.50 M(+20.7%) |
| Mar 1999 | - | $2.90 M(-3.3%) |
| Dec 1998 | $3.00 M(+15.4%) | $3.00 M(-6.3%) |
| Sept 1998 | - | $3.20 M(+23.1%) |
| June 1998 | - | $2.60 M(+13.0%) |
| Mar 1998 | - | $2.30 M(-11.5%) |
| Dec 1997 | $2.60 M(+18.2%) | $2.60 M(-13.3%) |
| Sept 1997 | - | $3.00 M(+25.0%) |
| June 1997 | - | $2.40 M(+14.3%) |
| Mar 1997 | - | $2.10 M(-4.5%) |
| Dec 1996 | $2.20 M(+57.1%) | $2.20 M(-4.3%) |
| Sept 1996 | - | $2.30 M(+109.1%) |
| June 1996 | - | $1.10 M(-38.9%) |
| Mar 1996 | - | $1.80 M(+28.6%) |
| Dec 1995 | $1.40 M(+55.6%) | $1.40 M(-46.2%) |
| Sept 1995 | - | $2.60 M(+188.9%) |
| Dec 1994 | $900.00 K | $900.00 K |
FAQ
- What is Achieve Life Sciences annual accounts payable?
- What is the all time high annual accounts payable for Achieve Life Sciences?
- What is Achieve Life Sciences annual accounts payable year-on-year change?
- What is Achieve Life Sciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Achieve Life Sciences?
- What is Achieve Life Sciences quarterly accounts payable year-on-year change?
What is Achieve Life Sciences annual accounts payable?
The current annual accounts payable of ACHV is $618.00 K
What is the all time high annual accounts payable for Achieve Life Sciences?
Achieve Life Sciences all-time high annual accounts payable is $5.67 M
What is Achieve Life Sciences annual accounts payable year-on-year change?
Over the past year, ACHV annual accounts payable has changed by -$1.04 M (-62.77%)
What is Achieve Life Sciences quarterly accounts payable?
The current quarterly accounts payable of ACHV is $1.01 M
What is the all time high quarterly accounts payable for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly accounts payable is $5.67 M
What is Achieve Life Sciences quarterly accounts payable year-on-year change?
Over the past year, ACHV quarterly accounts payable has changed by +$373.00 K (+58.46%)